Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis

American Journal of Human Genetics

Volumn 68, Issue 3, 2001, Pages 590-597

  Ericson, K G ^a   Fadeel, B ^a   Nilsson Ardnor, S ^a   Soderhall C ^a   Samuelsson, A ^a   Janka, G ^a   Schneider, M ^a   Gurgey A ^a   Yalman, N ^a   Revesz T ^a   Egeler, R M ^a   Jahnukainen, K ^a   Storm Mathiesen, I ^a   Haraldsson, A ^a   Poole, J ^a   De Saint Basile, G ^a   Nordenskjold M ^a   Henter, J I ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DNA; ETOPOSIDE; PERFORIN;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW TRANSPLANTATION; CHILD; CHROMOSOME 9; CLINICAL ARTICLE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HUMAN; INFANT; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0035092422     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/318796     Document Type: Article

References (34)

1. Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis
2. Proteases and cell-mediated cytotoxicity
3. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
4. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-q22 and evidence for heterogeneity
5. Genetic basis of hemophagocytic lymphohistiocytosis syndrome
6. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: A single-centre experience of 12 patients
7. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis
8. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis
9. Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients
10. Hypercytokinemia in hemophagocytic syndrome
11. Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH)
12. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia
13. HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis
14. Familial hemophagocytic lymphohistiocytosis: Primary hemophagocytic lymphohistiocytosis
15. Diagnostic guidelines for hemophagocytic lymphohistiocytosis
16. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
17. Hyper-interleukin (IL)-6-naemia in haemophagocytic lymphohistiocytosis
18. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors
19. Familial hemophagocytic lymphohistiocytosis
20. Homeostatic regulation of CD8+ T cells by perforin
21. Structure and function of human perforin
22. Structure of the human perforin gene: A simple gene organization with interesting potential regulatory sequences
23. Perforin: Structure and function
24. Perforin and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity
25. A role for perforin in downregulating T-cell responses during chronic viral infection
26. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping
27. Impaired natural killer activity in lymphohistiocytosis syndrome
28. Perforin: Structure, function, and regulation
29. Molecular cloning and chromosomal assignment of a human perforin (PFP) gene
30. Perforin gene defects in familial hemophagocytic lymphohistiocytosis
31. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives
32. Human Fas ligand: Gene structure, chromosomal location and species specificity
33. Perforin-mediated target cell lysis by cytolytic T lymphocytes
34. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans